Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. 4 Grant or award Director acquired 32,000 shares (grant or award)
  2. 4 Grant or award Director acquired 16,000 shares (grant or award)
  3. 4 Grant or award Director acquired 16,000 shares (grant or award)
  4. 4 Grant or award Director acquired 16,000 shares (grant or award)
  5. 4 Grant or award Director acquired 16,000 shares (grant or award)
  6. 4 Grant or award Director acquired 16,000 shares (grant or award)
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Open-market sale Director sold 39,000 shares at an average $26.84 ($1,046,782)
  9. SC 13G Stake Amended Statement of Ownership
  10. 8-K Event Results of operations · Regulation FD disclosure
  11. 8-K Event Material agreement
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change
  17. 4 Open-market sale Chief Scientific Officer sold 25,000 shares at an average $25.04 ($626,025)
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 4 Open-market sale Director sold 29,899 shares at $25.90 ($774,411)

Page 12 of 33 · 660 filings